References
- OttavianiGJaffeNThe epidemiology of osteosarcomaCancer Treat Res200915231320213383
- FergusonWSGoorinAMCurrent treatment of osteosarcomaCancer Invest200119329231511338887
- HoskingBMMuscatGEKoopmanPADowhanDHDunnTLTrans-activation and DNA-binding properties of the transcription factor, Sox-18Nucleic Acids Res19952314262626287651823
- HoskingBMWyethJRPennisiDJWangSCKoopmanPMuscatGECloning and functional analysis of the Sry-related HMG box gene, Sox18Gene20012621–223924711179689
- DongCWilhelmDKoopmanPSox genes and cancerCytogenet Genome Res20041052–444244715237232
- EomBWJoMJKookMCThe lymphangiogenic factor SOX 18: a key indicator to stage gastric tumor progressionInt J Cancer20121311414821796627
- WangYGuoHZhangDOverexpression of SOX18 correlates with accelerated cell growth and poor prognosis in human pancreatic ductal adenocarcinomaBiochem Biophys Res Commun2016479351051627663663
- PulaBOlbromskiMWojnarAImpact of SOX18 expression in cancer cells and vessels on the outcome of invasive ductal breast carcinomaCell Oncol (Dordr)201336646948324065215
- PulaBKobierzyckiCSolinskiDSOX18 expression predicts response to platinum-based chemotherapy in ovarian cancerAnticancer Res20143484029403725075026
- JethonAPulaBOlbromskiMPrognostic significance of SOX18 expression in non-small cell lung cancerInt J Oncol201546112313225310193
- WuZLiuJWangJZhangFSOX18 knockdown suppresses the proliferation and metastasis, and induces the apoptosis of osteosarcoma cellsMol Med Rep201613149750426573263
- HodgeDRHurtEMFarrarWLThe role of IL-6 and STAT3 in inflammation and cancerEur J Cancer200541162502251216199153
- WilliamsJGSTAT signalling in cell proliferation and in developmentCurr Opin Genet Dev200010550350710980427
- BattleTEFrankDAThe role of STATs in apoptosisCurr Mol Med20022438139212108949
- BrombergJFWrzeszczynskaMHDevganGStat3 as an oncogeneCell199998329530310458605
- RyuKChoyEYangCActivation of signal transducer and activator of transcription 3 (Stat3) pathway in osteosarcoma cells and overexpression of phosphorylated-Stat3 correlates with poor prognosisJ Orthop Res201028797197820063378
- FoshayKMGallicanoGIRegulation of Sox2 by STAT3 initiates commitment to the neural precursor cell fateStem Cells Dev200817226927818447642
- YangJLiaoDChenCTumor-associated macrophages regulate murine breast cancer stem cells through a novel paracrine EGFR/Stat3/Sox-2 signaling pathwayStem Cells201331224825823169551
- OkamotoMLeeCOyasuRInterleukin-6 as a paracrine and autocrine growth factor in human prostatic carcinoma cells in vitroCancer Res19975711411468988055
- OkamotoMHattoriKOyasuRInterleukin-6 functions as an autocrine growth factor in human bladder carcinoma cell lines in vitroInt J Cancer19977211491549212236
- MikiSIwanoMMikiYInterleukin-6 (IL-6) functions as an in vitro autocrine growth factor in renal cell carcinomasFEBS Lett198925026076102787758
- KubbenFJPeeters-HaesevoetsAEngelsLGProliferating cell nuclear antigen (PCNA): a new marker to study human colonic cell proliferationGut19943545305357909785
- ReedJCRegulation of apoptosis by bcl-2 family proteins and its role in cancer and chemoresistanceCurr Opin Oncol1995765415468547403
- SekiKYoshikawaHShiikiKHamadaYAkamatsuNTasakaKCisplatin (CDDP) specifically induces apoptosis via sequential activation of caspase-8, -3 and -6 in osteosarcomaCancer Chemother Pharmacol200045319920610663637
- KuwaharaMYamashitaMShinodaKThe transcription factor Sox4 is a downstream target of signaling by the cytokine TGF-[beta] and suppresses TH2 differentiationNat Immunol201213877878622751141
- LinY-MChangZ-LLiaoY-YChouM-CTangC-HIL-6 promotes ICAM-1 expression and cell motility in human osteosarcomaCancer Lett2013328113514322939995